1. Anti-infection Metabolic Enzyme/Protease
  2. Parasite Fungal Phosphatase Bacterial Antibiotic
  3. Pentamidine

Pentamidine  (Synonyms: 喷他脒; MP-601205)

目录号: HY-B0537 纯度: 97.19%
COA 产品使用指南 技术支持

Pentamidine (MP-601205) 是一种抗微生物剂,会干扰 DNA 的生物合成。Pentamidine 抑制寄生虫 Leishmania infantumIC50 为 2.5 μM。Pentamidine 是一种有效的选择性蛋白酪氨酸磷酸酶 (PTPases) 和再生肝磷酸酶 (PRL) 抑制剂。Pentamidine 可用于冈比亚锥虫病,抗锑利什曼病和卡氏肺孢子虫肺炎的研究。抗肿瘤活性,抗菌活性。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Pentamidine Chemical Structure

Pentamidine Chemical Structure

CAS No. : 100-33-4

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
5 mg ¥340
In-stock
10 mg ¥550
In-stock
25 mg ¥1100
In-stock
50 mg ¥1700
In-stock
100 mg ¥2750
In-stock
200 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

Other Forms of Pentamidine:

    Pentamidine purchased from MCE. Usage Cited in: BMC Womens Health. 2022 Nov 24;22(1):470.  [Abstract]

    Pentamidine (2.5, 5 μM; 24-36 h) reduces cell migration in a dose- and time-dependent manner, in Ishikawa and HEC-1A cells.
    • 生物活性

    • 纯度 & 产品资料

    • 参考文献

    生物活性

    Pentamidine (MP-601205) is an antimicrobial agent and interferes with DNA biosynthetics. Pentamidine inhibits parasite Leishmania infantum with an IC50 of 2.5 μM. Pentamidine is a potent and selective protein tyrosine phosphatases (PTPases) and phosphatase of regenerating liver (PRL) inhibitor. Pentamidine has the potential for Gambian trypanosomiasis, antimony-resistant leishmaniasis, and Pneumocystis carinii pneumonia treatment. Antitumor and antibacterial activities[1][2][3][4].

    IC50 & Target

    Trypanosoma

     

    Leishmania

     

    细胞效力
    (Cellular Effect)
    Cell Line Type Value Description References
    786-0 IC50
    > 100 μM
    Compound: PEN
    Cytotoxicity against human 786-O cells assessed as decrease in mitochondrial viability after 6 hrs by CMXRos staining based assay
    Cytotoxicity against human 786-O cells assessed as decrease in mitochondrial viability after 6 hrs by CMXRos staining based assay
    [PMID: 29407968]
    786-0 IC50
    > 25 μM
    Compound: PEN
    Mitochondrial toxicity in human 786-O cells measured after 6 hrs by MitoTracker Red chloromethyl-X-rosamine based assay
    Mitochondrial toxicity in human 786-O cells measured after 6 hrs by MitoTracker Red chloromethyl-X-rosamine based assay
    [PMID: 30908048]
    A549 GI50
    > 100 μM
    Compound: Pentamidine
    Cytotoxicity against human A549 cells assessed as cell growth by Cell titer-Glo assay
    Cytotoxicity against human A549 cells assessed as cell growth by Cell titer-Glo assay
    [PMID: 28064141]
    A549 IC50
    > 100 μM
    Compound: PEN
    Cytotoxicity against human A549 cells after 48 hrs by CellTiter-Glo assay
    Cytotoxicity against human A549 cells after 48 hrs by CellTiter-Glo assay
    [PMID: 29407968]
    A549 GI50
    > 25 μM
    Compound: PEN
    Cytotoxicity against human A549 cells after 48 hrs by Celltiter-glo assay
    Cytotoxicity against human A549 cells after 48 hrs by Celltiter-glo assay
    [PMID: 30908048]
    A549 IC50
    23.5 μM
    Compound: Pentamidine
    Cytotoxicity against human A549 cells assessed as decrease in cell viability after 24 to 72 hrs by ATP-based luciferin-luciferase assay
    Cytotoxicity against human A549 cells assessed as decrease in cell viability after 24 to 72 hrs by ATP-based luciferin-luciferase assay
    [PMID: 30108719]
    Astrocyte EC50
    1.995 μM
    Compound: 32
    Antiproliferative activity against mouse astrocyte cells by MTT assay
    Antiproliferative activity against mouse astrocyte cells by MTT assay
    [PMID: 17417631]
    CHO IC50
    38 μM
    Compound: 4, Pentacarinat, Nebupent, Pentam
    Inhibition of mouse hippocampal neurons ASIC transfected in CHO cells assessed as inhibition of acid-evoked current at -60 mV holding potential by two-electrode voltage-clamp electrophysiology assay
    Inhibition of mouse hippocampal neurons ASIC transfected in CHO cells assessed as inhibition of acid-evoked current at -60 mV holding potential by two-electrode voltage-clamp electrophysiology assay
    [PMID: 24630693]
    HEK293 EC50
    > 100 μM
    Compound: Pentamidine
    Cytotoxicity against HEK293 cells assessed as reduction in cell viability after 48 hrs by alamar blue assay
    Cytotoxicity against HEK293 cells assessed as reduction in cell viability after 48 hrs by alamar blue assay
    [PMID: 27720295]
    HEK293 CC50
    > 4 μM
    Compound: Pentamidine
    Cytotoxicity against human HEK293 cells assessed as reduction in cell viability at 20 uM measured after 48 hrs by resazurin reagent based multilabel reader analysis
    Cytotoxicity against human HEK293 cells assessed as reduction in cell viability at 20 uM measured after 48 hrs by resazurin reagent based multilabel reader analysis
    [PMID: 36608774]
    HEK293 CC50
    0.67 μM
    Compound: Pentamidine
    Cytotoxicity against human HEK293 cells assessed as reduction in cell viability measured after 48 hrs by resazurin assay
    Cytotoxicity against human HEK293 cells assessed as reduction in cell viability measured after 48 hrs by resazurin assay
    [PMID: 33479668]
    HEK293 IC50
    1.2 μM
    Compound: pentamidine
    Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay
    Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay
    [PMID: 23241029]
    HEK293 IC50
    10.4 μM
    Compound: pentamidine
    Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay
    Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay
    [PMID: 23241029]
    HEK293 IC50
    2 μM
    Compound: pentamidine
    Inhibition of human MATE1-mediated [14]-metformin uptake expressed in HEK293 cells after 1.5 mins by scintillation counting analysis
    Inhibition of human MATE1-mediated [14]-metformin uptake expressed in HEK293 cells after 1.5 mins by scintillation counting analysis
    [PMID: 23241029]
    HEK293 IC50
    2.7 μM
    Compound: pentamidine
    Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells up to 500 uM after 1.5 mins by fluorescence assay
    Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells up to 500 uM after 1.5 mins by fluorescence assay
    [PMID: 23241029]
    HEK293 IC50
    2.7 μM
    Compound: pentamidine
    Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay
    Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay
    [PMID: 23241029]
    HEK293 IC50
    22.1 μM
    Compound: pentamidine
    Inhibition of human OCT1-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay
    Inhibition of human OCT1-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay
    [PMID: 23241029]
    HEK293 IC50
    71 μM
    Compound: Pentamidine
    Cytotoxicity against human HEK293 cells after 48 hrs by by alamar blue assay
    Cytotoxicity against human HEK293 cells after 48 hrs by by alamar blue assay
    [PMID: 21705225]
    HEK293 IC50
    9.5 μM
    Compound: pentamidine
    Inhibition of human OCT3-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay
    Inhibition of human OCT3-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay
    [PMID: 23241029]
    HeLa IC50
    0.005 μM
    Compound: Pentamidine
    Antitrypanosomal activity against bloodstream trypomastigote form of Trypanosoma brucei brucei 65.3 infected in human HeLa cells after 72 hrs by Alamar Blue assay
    Antitrypanosomal activity against bloodstream trypomastigote form of Trypanosoma brucei brucei 65.3 infected in human HeLa cells after 72 hrs by Alamar Blue assay
    [PMID: 27912173]
    HeLa IC50
    15 μM
    Compound: Pentamidine
    Cytotoxicity against human HeLa cells after 96 hrs by resazurin-based spectrofluorimetric method
    Cytotoxicity against human HeLa cells after 96 hrs by resazurin-based spectrofluorimetric method
    [PMID: 23164660]
    HepG2 IC50
    159.71 μM
    Compound: Pentamidine
    Cytotoxicity against human HepG2 cells by MTT assay
    Cytotoxicity against human HepG2 cells by MTT assay
    [PMID: 24630563]
    HepG2 CC50
    2.3 μM
    Compound: Pentamidine
    Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
    [PMID: 30655943]
    HepG2 CC50
    2.3 μM
    Compound: Pentamidine
    Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
    [PMID: 25846065]
    HepG2 CC50
    2.3 μM
    Compound: Pentamidine
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    [PMID: 25559208]
    HepG2 CC50
    2.3 μM
    Compound: Pentamidine, Pentacarinat
    Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
    [PMID: 24858543]
    HepG2 CC50
    2.3 μM
    Compound: Pentamidine
    Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
    [PMID: 24080103]
    HepG2 CC50
    2.3 μM
    Compound: Pentamidine
    Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
    [PMID: 22608675]
    J774 IC50
    20.43 μM
    Compound: Pentamidine
    Antileishmanial activity against Leishmania donovani (MHOM/IN/Dd8) amastigote infected in mouse J774 cells assessed as after 72 hrs by luminometry
    Antileishmanial activity against Leishmania donovani (MHOM/IN/Dd8) amastigote infected in mouse J774 cells assessed as after 72 hrs by luminometry
    [PMID: 20371140]
    J774 IC50
    70 μM
    Compound: P
    Cytotoxicity against mouse J774 cells after 72 hrs by MTT assay
    Cytotoxicity against mouse J774 cells after 72 hrs by MTT assay
    [PMID: 22000949]
    J774.1 IC50
    1 μM
    Compound: Pentamidine
    Cytotoxicity against mouse J774A.1 cells after 72 hrs by MTT assay
    Cytotoxicity against mouse J774A.1 cells after 72 hrs by MTT assay
    [PMID: 25846065]
    J774.1 CC50
    1 μM
    Compound: Pentamidine
    Cytotoxicity against mouse J774.1 cells after 72 hrs by MTT assay
    Cytotoxicity against mouse J774.1 cells after 72 hrs by MTT assay
    [PMID: 24080103]
    J774.1 IC50
    38.6 μM
    Compound: Pentamidine
    Cytotoxicity against mouse J774.1 cells after 24 hrs by alamar blue assay
    Cytotoxicity against mouse J774.1 cells after 24 hrs by alamar blue assay
    [PMID: 28698054]
    J774.A1 IC50
    > 20 μM
    Compound: Pentamidine
    Antileishmanial activity against intracellular amastigote stage of Leishmania infantum MHOM/MA/67/ITMAP-263 expressing luciferase infected in mouse J774A1 cells assessed as inhibition of metabolic activity after 120 hrs by luminescence assay
    Antileishmanial activity against intracellular amastigote stage of Leishmania infantum MHOM/MA/67/ITMAP-263 expressing luciferase infected in mouse J774A1 cells assessed as inhibition of metabolic activity after 120 hrs by luminescence assay
    [PMID: 25846065]
    J774.A1 CC50
    0.56 μM
    Compound: Pentamidine
    Cytotoxicity against mouse J774A1 cells incubated for 72 hrs by MTT assay
    Cytotoxicity against mouse J774A1 cells incubated for 72 hrs by MTT assay
    [PMID: 25282267]
    J774.A1 CC50
    0.56 μM
    Compound: Pentamidine, Pentacarinat
    Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
    Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
    [PMID: 24858543]
    J774.A1 CC50
    1 μM
    Compound: Pentamidine
    Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
    Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
    [PMID: 22608675]
    J774.A1 IC50
    1.03 μM
    Compound: Pentamidine
    Cytotoxic activity against mouse J774A1 cells after 72 hrs by MTT assay
    Cytotoxic activity against mouse J774A1 cells after 72 hrs by MTT assay
    [PMID: 21555166]
    J774.A1 IC50
    12.11 μg/mL
    Compound: Pentamidine
    Antileishmanial activity against Leishmania donovani MHOM/IN/Dd8 amastigotes infected in mouse J774A1 cells assessed as luciferase activity after 48 hrs
    Antileishmanial activity against Leishmania donovani MHOM/IN/Dd8 amastigotes infected in mouse J774A1 cells assessed as luciferase activity after 48 hrs
    [PMID: 19328690]
    J774.A1 IC50
    12.11 μg/mL
    Compound: Pentamidine
    Antileishmanial activity against Leishmania donovani intracellular amastigotes infected in mouse J774A1 cells after 48 hrs by luciferase activity-based drug susceptibility assay
    Antileishmanial activity against Leishmania donovani intracellular amastigotes infected in mouse J774A1 cells after 48 hrs by luciferase activity-based drug susceptibility assay
    [PMID: 19091566]
    J774.A1 IC50
    12.11 μg/mL
    Compound: Pentamidine
    Antileishmanial activity against amastigote of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J774A1 cells after 72 hrs by luciferase reporter gene assay
    Antileishmanial activity against amastigote of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J774A1 cells after 72 hrs by luciferase reporter gene assay
    [PMID: 20457476]
    J774.A1 IC50
    12.9 μg/mL
    Compound: Pentamidine
    Cytotoxicity against mouse J774A1 cells after 72 hrs by cell-titer assay
    Cytotoxicity against mouse J774A1 cells after 72 hrs by cell-titer assay
    [PMID: 15679330]
    J774.A1 IC50
    13.68 μM
    Compound: PM
    Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay
    Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay
    [PMID: 24900613]
    J774.A1 IC50
    20.43 μM
    Compound: Pentamidine
    Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells assessed as inhibition of parasite growth after 72 hrs by luciferase reporter gene assay
    Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells assessed as inhibition of parasite growth after 72 hrs by luciferase reporter gene assay
    [PMID: 20850302]
    J774.A1 CC50
    25.15 μg/mL
    Compound: Pentamidine
    Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
    Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
    [PMID: 20457476]
    J774.A1 IC50
    3.59 μg/mL
    Compound: Pentamidine
    Antileishmanial activity against Leishmania donovani MHOM/IN/Dd8 amastigote carrying firefly luciferase gene infected in mouse J774A1 cells assessed as relative luminescence unit after 72 hrs
    Antileishmanial activity against Leishmania donovani MHOM/IN/Dd8 amastigote carrying firefly luciferase gene infected in mouse J774A1 cells assessed as relative luminescence unit after 72 hrs
    [PMID: 20199824]
    J774.A1 CC50
    3.91 μg/mL
    Compound: Pentamidine
    Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
    Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
    [PMID: 20199824]
    J774.A1 CC50
    31.31 μg/mL
    Compound: Pentamidine
    Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
    Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
    [PMID: 19217698]
    J774.A1 CC50
    31.31 μg/mL
    Compound: Pentamidine
    Cytotoxicity against mouse J774A1 cells by MTT assay
    Cytotoxicity against mouse J774A1 cells by MTT assay
    [PMID: 19913413]
    J774.A1 CC50
    31.31 μg/mL
    Compound: Pentamidine
    Cytotoxicity against mouse J774A1 cells after 48 hrs by Geimsa staining method
    Cytotoxicity against mouse J774A1 cells after 48 hrs by Geimsa staining method
    [PMID: 19091566]
    J774.A1 CC50
    52.82 μM
    Compound: Pentamidine
    Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
    Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
    [PMID: 20371140]
    KB CC50
    52.7 μM
    Compound: Pentamidine
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    [PMID: 23182089]
    L6 IC50
    1.51 μM
    Compound: pentamidine
    Cytotoxicity against rat L6 cells after 70 hrs by resazurin reduction assay
    Cytotoxicity against rat L6 cells after 70 hrs by resazurin reduction assay
    [PMID: 23301592]
    L6 IC50
    2.1 μM
    Compound: I
    Cytotoxicity against rat L6 cells after 72 hrs by alamar blue staining-based microplate fluorometric analysis
    Cytotoxicity against rat L6 cells after 72 hrs by alamar blue staining-based microplate fluorometric analysis
    [PMID: 22005186]
    L6 IC50
    2100 nM
    Compound: 1
    Cytotoxicity against rat L6 cells assessed as cell viability after 70 hrs by Alamar blue assay
    Cytotoxicity against rat L6 cells assessed as cell viability after 70 hrs by Alamar blue assay
    [PMID: 24012380]
    L6 IC50
    25 μM
    Compound: Pentamidine
    Cytotoxicity against rat L6 cells after 70 hrs by alamar blue assay
    Cytotoxicity against rat L6 cells after 70 hrs by alamar blue assay
    [PMID: 21112788]
    L6 IC50
    31.8 μM
    Compound: Pentamidine
    Cytotoxicity against rat L6 cells measured after 70 hrs by alamar blue staining based fluorescence analysis
    Cytotoxicity against rat L6 cells measured after 70 hrs by alamar blue staining based fluorescence analysis
    [PMID: 27102161]
    L6 IC50
    46 μM
    Compound: PNT
    Cytotoxicity against rat L6 cells by Alamar blue assay
    Cytotoxicity against rat L6 cells by Alamar blue assay
    [PMID: 34146914]
    L6 IC50
    46.6 mM
    Compound: PMD
    Cytotoxicity against rat L6 cells after 72 hrs by Alamar blue assay
    Cytotoxicity against rat L6 cells after 72 hrs by Alamar blue assay
    [PMID: 23871911]
    L6 IC50
    46.6 nM
    Compound: Pentamidine
    Cytotoxicity against rat L6 cells by alamar blue assay
    Cytotoxicity against rat L6 cells by alamar blue assay
    [PMID: 17178177]
    L6 IC50
    46.6 μM
    Compound: Pentamidine
    Cytotoxicity against rat L6 cells after 3 days by Alamar blue assay
    Cytotoxicity against rat L6 cells after 3 days by Alamar blue assay
    [PMID: 24956553]
    L6 IC50
    46.6 μM
    Compound: PMD, Pentamidine
    Cytotoxicity against rat L6 cells assessed as cell viability after 70 hrs by Alamar blue assay
    Cytotoxicity against rat L6 cells assessed as cell viability after 70 hrs by Alamar blue assay
    [PMID: 24268543]
    L6 IC50
    46.6 μM
    Compound: PMD
    Cytotoxicity against rat L6 cells after 70 hrs by alamar blue assay
    Cytotoxicity against rat L6 cells after 70 hrs by alamar blue assay
    [PMID: 19928900]
    L6 IC50
    46.6 μM
    Compound: PMD
    Cytotoxicity against rat L6 cells after 70 hrs by alamar blue assay
    Cytotoxicity against rat L6 cells after 70 hrs by alamar blue assay
    [PMID: 19757840]
    L6 IC50
    46.6 μM
    Compound: PMD
    Cytotoxicity against rat L6 cells after 70 hrs by alamar blue assay
    Cytotoxicity against rat L6 cells after 70 hrs by alamar blue assay
    [PMID: 19606902]
    L6 IC50
    46.6 μM
    Compound: PMD, Pentamidine
    Cytotoxicity against rat L6 cells after 72 hrs by Alamar Blue assay
    Cytotoxicity against rat L6 cells after 72 hrs by Alamar Blue assay
    [PMID: 23795673]
    L6 IC50
    6 μM
    Compound: Pentamidine
    Cytotoxicity against rat L6 cells by alamar blue assay
    Cytotoxicity against rat L6 cells by alamar blue assay
    [PMID: 21194955]
    LLC-MK2 IC50
    25.61 μM
    Compound: Pentamidine
    Cytotoxicity against rhesus monkey LLC-MK2 cells after 48 hrs by MTT assay
    Cytotoxicity against rhesus monkey LLC-MK2 cells after 48 hrs by MTT assay
    [PMID: 20934347]
    Macrophage CC50
    10 μM
    Compound: Pentamidine
    Cytotoxicity against human THP-1 derived macrophages by colorimetric MTT assay
    Cytotoxicity against human THP-1 derived macrophages by colorimetric MTT assay
    [PMID: 35675511]
    Macrophage IC50
    8.7 μg/mL
    Compound: pentamidine
    Cytotoxicity against human macrophages after 48 hrs by MTT assay
    Cytotoxicity against human macrophages after 48 hrs by MTT assay
    [PMID: 18177008]
    Malme-3M IC50
    10.2 μM
    Compound: SBi1
    Growth inhibition of human MALME-3M cells overexpressing calcium-binding protein S100B after 4 days by SYBR green assay
    Growth inhibition of human MALME-3M cells overexpressing calcium-binding protein S100B after 4 days by SYBR green assay
    [PMID: 23264854]
    Malme-3M IC50
    12.2 μM
    Compound: SBi1
    Growth inhibition of human MALME-3M cells transfected with S100B siRNA after 4 days by SYBR green assay
    Growth inhibition of human MALME-3M cells transfected with S100B siRNA after 4 days by SYBR green assay
    [PMID: 23264854]
    MDCK-II IC50
    0.41 μM
    Compound: pentamidine
    Inhibition of human MATE1-mediated [14]-metformin uptake expressed in polarized MDCK2 cells after 5 mins by liquid scintillation counting analysis
    Inhibition of human MATE1-mediated [14]-metformin uptake expressed in polarized MDCK2 cells after 5 mins by liquid scintillation counting analysis
    [PMID: 23241029]
    MRC5 IC50
    5.71 μg/mL
    Compound: pentamidine
    Cytotoxicity against human MRC5 cells after 7 days by MTT assay
    Cytotoxicity against human MRC5 cells after 7 days by MTT assay
    [PMID: 19013823]
    Peritoneal macrophage CC50
    35.7 μM
    Compound: Pentamidine
    Cytotoxicity against mouse peritoneal macrophages assessed as decrease in cell viability after 24 hrs by MTT assay
    Cytotoxicity against mouse peritoneal macrophages assessed as decrease in cell viability after 24 hrs by MTT assay
    [PMID: 30913526]
    Peritoneal macrophage CC50
    8.5 μM
    Compound: Pentamidine
    Cytotoxicity against Balb/c mouse peritoneal macrophages assessed as reduction in cell viability after 72 hrs by resazurin assay
    Cytotoxicity against Balb/c mouse peritoneal macrophages assessed as reduction in cell viability after 72 hrs by resazurin assay
    [PMID: 29459275]
    Peritoneal macrophage cell CC50
    11.22 μM
    Compound: Pentamidine
    Cytotoxicity against mouse peritoneal macrophages assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    Cytotoxicity against mouse peritoneal macrophages assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    [PMID: 26112378]
    Peritoneal macrophage cell IC50
    152.7 μM
    Compound: Pentamidine
    Cytotoxicity against BALB/c mouse peritoneal macrophages assessed as cell viability after 48 hrs by trypan blue dye exclusion method
    Cytotoxicity against BALB/c mouse peritoneal macrophages assessed as cell viability after 48 hrs by trypan blue dye exclusion method
    [PMID: 26383125]
    Peritoneal macrophage cell CC50
    26.3 μM
    Compound: Pentamidine
    Cytotoxicity against Swiss mouse peritoneal macrophages at 20 uM after 5 days by MTT assay
    Cytotoxicity against Swiss mouse peritoneal macrophages at 20 uM after 5 days by MTT assay
    [PMID: 23851117]
    Peritoneal macrophage cell CC50
    3.82 μg/mL
    Compound: Pentamidine
    Cytotoxicity against mouse peritoneal macrophages after 72 hrs by MTT assay
    Cytotoxicity against mouse peritoneal macrophages after 72 hrs by MTT assay
    [PMID: 23623672]
    Peritoneal macrophage cell IC50
    30.4 μM
    Compound: pentamidine
    Cytotoxicity against mouse Peritoneal macrophages cells after 72 hrs by MTS assay
    Cytotoxicity against mouse Peritoneal macrophages cells after 72 hrs by MTS assay
    [PMID: 22989363]
    Peritoneal macrophage cell EC50
    35.69 μM
    Compound: Pent
    Cytotoxicity against BALB/c mouse peritoneal macrophages incubated for 24 hrs by MTT assay
    Cytotoxicity against BALB/c mouse peritoneal macrophages incubated for 24 hrs by MTT assay
    [PMID: 26055530]
    Peritoneal macrophage cell CC50
    35.7 μM
    Compound: Pentamidine
    Cytotoxicity against Swiss albino mouse peritoneal macrophages after 24 hrs by MTT assay
    Cytotoxicity against Swiss albino mouse peritoneal macrophages after 24 hrs by MTT assay
    [PMID: 26169126]
    RAW264.7 CC50
    > 100 μM
    Compound: Pentamidine
    Cytotoxicity against mouse RAW264.7 cells assessed as cell growth inhibition after 72 hrs by Alamar blue dye-based assay
    Cytotoxicity against mouse RAW264.7 cells assessed as cell growth inhibition after 72 hrs by Alamar blue dye-based assay
    [PMID: 27793448]
    RAW264.7 CC50
    25.5 μM
    Compound: Pentamidine
    Cytotoxicity against mouse RAW264.7 cells after 24 hrs by MTT assay
    Cytotoxicity against mouse RAW264.7 cells after 24 hrs by MTT assay
    [PMID: 24125880]
    RAW264.7 IC50
    30 μM
    Compound: pentamidine
    Cytotoxicity against mouse RAW264.7 cells after 72 hrs by MTS assay
    Cytotoxicity against mouse RAW264.7 cells after 72 hrs by MTS assay
    [PMID: 22989363]
    RAW264.7 IC50
    4.21 μM
    Compound: Pentamidine
    Antikinetoplastid activity against Leishmania donovani LV9 axenic amastigotes in mouse RAW264.7 cells assessed as viability measured 24 hrs by SYBR green assay
    Antikinetoplastid activity against Leishmania donovani LV9 axenic amastigotes in mouse RAW264.7 cells assessed as viability measured 24 hrs by SYBR green assay
    [PMID: 25499437]
    RAW264.7 EC50
    5.3 μg/mL
    Compound: Pentamidine
    Antileishmanial activity against axenically cultured Leishmania infantum chagasi MHOM/BR/00/1669 promastigotes infected in mouse RAW264.7 cells assessed as inhibition of parasite growth after 48 hrs
    Antileishmanial activity against axenically cultured Leishmania infantum chagasi MHOM/BR/00/1669 promastigotes infected in mouse RAW264.7 cells assessed as inhibition of parasite growth after 48 hrs
    [PMID: 25281268]
    THP-1 IC50
    > 10 μg/mL
    Compound: Pentamidine
    Cytotoxicity against human THP1 cells after 48 hrs by Alamar blue assay
    Cytotoxicity against human THP1 cells after 48 hrs by Alamar blue assay
    [PMID: 25240614]
    THP-1 CC50
    > 10 μM
    Compound: Pentamidine
    Cytotoxicity against human THP-1 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    Cytotoxicity against human THP-1 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
    [PMID: 35178179]
    THP-1 IC50
    > 20 μM
    Compound: Pentamidine
    Antileishmanial activity against intracellular amastigote stage of Leishmania donovani MHOM/IN/00/DEVI infected in human THP1 cells assessed as decrease infected macrophages after 120 hrs by microscopy
    Antileishmanial activity against intracellular amastigote stage of Leishmania donovani MHOM/IN/00/DEVI infected in human THP1 cells assessed as decrease infected macrophages after 120 hrs by microscopy
    [PMID: 25846065]
    THP-1 IC50
    > 20 μM
    Compound: Pentamidine
    Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI intracellular amastigotes infected in human THP1 cells assessed as reduction in parasite-infected macrophages incubated for 120 hrs by Giemsa staining based microscopy
    Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI intracellular amastigotes infected in human THP1 cells assessed as reduction in parasite-infected macrophages incubated for 120 hrs by Giemsa staining based microscopy
    [PMID: 25559208]
    THP-1 IC50
    0.4 μg/mL
    Compound: Pentamidine
    Antileishmanial activity against amastigote stage of Leishmania donovani infected in human THP1 cells after 48 hrs by Alamar blue assay
    Antileishmanial activity against amastigote stage of Leishmania donovani infected in human THP1 cells after 48 hrs by Alamar blue assay
    [PMID: 25240614]
    THP-1 IC50
    1.6 nM
    Compound: pentamidine
    Antiparasitic activity against bloodstream form of Trypanosoma brucei brucei 427 infected in macrophages differentiated from human THP1 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay
    Antiparasitic activity against bloodstream form of Trypanosoma brucei brucei 427 infected in macrophages differentiated from human THP1 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay
    [PMID: 26322631]
    THP-1 IC50
    10 μg/mL
    Compound: PEN
    Antileishmanial activity against wild-type Leishmania infantum MHOM/MA/67/ITMAP-263 promastigotes infected in human THP1 cells by luciferase based assay
    Antileishmanial activity against wild-type Leishmania infantum MHOM/MA/67/ITMAP-263 promastigotes infected in human THP1 cells by luciferase based assay
    [PMID: 17452480]
    THP-1 CC50
    10 μM
    Compound: PEN
    Cytotoxicity against human THP1 cells assessed as decrease in viable cells after 72 hrs by MTT assay
    Cytotoxicity against human THP1 cells assessed as decrease in viable cells after 72 hrs by MTT assay
    [PMID: 29407968]
    THP-1 IC50
    2 μM
    Compound: Pentamidine
    Antimicrobial activity against promastigote stage of Leishmania donovani infected in human THP1 cells after 72 hrs by Alamar Blue assay
    Antimicrobial activity against promastigote stage of Leishmania donovani infected in human THP1 cells after 72 hrs by Alamar Blue assay
    [PMID: 24980054]
    THP-1 IC50
    31.2 μM
    Compound: Pentamidine
    Cytotoxicity against human THP1 cells after 72 hrs by flow cytometry
    Cytotoxicity against human THP1 cells after 72 hrs by flow cytometry
    [PMID: 20833057]
    THP-1 IC50
    31.2 μM
    Compound: Pentamidine
    Cytotoxicity against human THP1 cells after 72 hrs by MTT assay
    Cytotoxicity against human THP1 cells after 72 hrs by MTT assay
    [PMID: 25846065]
    THP-1 CC50
    31.2 μM
    Compound: Pentamidine
    Cytotoxicity against human THP1 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    Cytotoxicity against human THP1 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    [PMID: 25559208]
    THP-1 IC50
    5.1 μg/mL
    Compound: PEN
    Antileishmanial activity against wild-type Leishmania major LV39 promastigotes infected in human THP1 cells by luciferase based assay
    Antileishmanial activity against wild-type Leishmania major LV39 promastigotes infected in human THP1 cells by luciferase based assay
    [PMID: 17452480]
    THP-1 CC50
    51.8 μM
    Compound: Pentamidine
    Cytotoxicity in human THP-1 cells assessed as reduction in cell viability incubated for 48 hrs hrs by MTT assay
    Cytotoxicity in human THP-1 cells assessed as reduction in cell viability incubated for 48 hrs hrs by MTT assay
    [PMID: 36105326]
    THP-1 IC50
    6.8 μg/mL
    Compound: PEN
    Antileishmanial activity against wild-type Leishmania amazonensis MHOM/BR/1973/MM2269 promastigotes infected in human THP1 cells by luciferase based assay
    Antileishmanial activity against wild-type Leishmania amazonensis MHOM/BR/1973/MM2269 promastigotes infected in human THP1 cells by luciferase based assay
    [PMID: 17452480]
    THP-1 IC50
    7.02 μM
    Compound: Pentamidine
    Antileishmanial activity against Leishmania major JISH118 promastigotes infected in human THP1 cells by Giemsa staining method
    Antileishmanial activity against Leishmania major JISH118 promastigotes infected in human THP1 cells by Giemsa staining method
    [PMID: 25069019]
    Vero IC50
    > 100 μM
    Compound: 3
    Cytotoxicity against african green monkey Vero cells by neutral red assay
    Cytotoxicity against african green monkey Vero cells by neutral red assay
    [PMID: 18367395]
    Vero IC50
    > 50 μg/mL
    Compound: Pentamidine
    Cytotoxicity against african green monkey Vero cells after 72 hrs by cell-titer assay
    Cytotoxicity against african green monkey Vero cells after 72 hrs by cell-titer assay
    [PMID: 15679330]
    Vero CC50
    47 μM
    Compound: Pentamidine
    Cytotoxicity against african green monkey Vero cells after 72 hrs by MTT assay
    Cytotoxicity against african green monkey Vero cells after 72 hrs by MTT assay
    [PMID: 21397502]
    Vero CC50
    47 μM
    Compound: Pentamidine
    Cytotoxicity against African green monkey Vero cells incubated for 24 to 48 hrs by SRB assay
    Cytotoxicity against African green monkey Vero cells incubated for 24 to 48 hrs by SRB assay
    [PMID: 28645659]
    Vero CC50
    47 μM
    Compound: Pentamidine
    Cytotoxicity against African green monkey Vero cells assessed as cell viability after 48 hrs by SRB assay
    Cytotoxicity against African green monkey Vero cells assessed as cell viability after 48 hrs by SRB assay
    [PMID: 24529307]
    Vero IC50
    57 μM
    Compound: Pentamidine
    Cytotoxicity against african green monkey Vero cells assessed as growth inhibition after 72 hrs by MTS assay
    Cytotoxicity against african green monkey Vero cells assessed as growth inhibition after 72 hrs by MTS assay
    [PMID: 23727538]
    Vero CC50
    85.86 μM
    Compound: PM
    Cytotoxicity against African green monkey Vero cells assessed as cell viability after 72 hrs by MTT assay
    Cytotoxicity against African green monkey Vero cells assessed as cell viability after 72 hrs by MTT assay
    [PMID: 24900613]
    WM-115 EC50
    16.3 μM
    Compound: 4b
    Growth inhibition of human WM115 cells expressing high levels of S100-B by SYBR Green based fluorescence method
    Growth inhibition of human WM115 cells expressing high levels of S100-B by SYBR Green based fluorescence method
    [PMID: 26727270]
    WM-115 EC50
    16.7 μM
    Compound: 4b
    Growth inhibition of human WM115 cells expressing low levels of S100-B by SYBR Green based fluorescence method
    Growth inhibition of human WM115 cells expressing low levels of S100-B by SYBR Green based fluorescence method
    [PMID: 26727270]
    WM-115 IC50
    4.8 μM
    Compound: pentamidine
    Cytotoxicity against human WM115 cells assessed as growth inhibition measured after 72 hrs by crystal violet assay
    Cytotoxicity against human WM115 cells assessed as growth inhibition measured after 72 hrs by crystal violet assay
    [PMID: 23375094]
    体外研究
    (In Vitro)

    Pentamidine (0-10 µg/mL; 6 days; WM9, DU145, C4-2, Hey, WM480, and A549 cells) treatment inhibits the growth of cancer cells in a concentration-dependent manner[1].
    The cytotoxic properties of Pentamidine isethionate towards the promastigotes of the protozoan parasite Leishmania infantum is determined. The leishmanicidal activity of Pentamidine isethionate is 60 times higher after 72 h of incubation than that of Cisplatin. Pentamidine isethionate induces a higher amount of programmed cell death (PCD) than Cisplatin, which is associated with inhibition of DNA synthesis and cell-cycle arrest in the G2/M phase. Binding of Pentamidine isethionate to calf-thymus DNA (CT-DNA) induces conformational changes in the DNA double helix, consistent with a B-->A transition. The interaction of Pentamidine isethionate with ubiquitin leads to a 6% increase in the beta-sheet content of the protein[2].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Cell Viability Assay[1]

    Cell Line: WM9, DU145, C4-2, Hey, WM480, and A549 cells
    Concentration: 0-10 µg/mL
    Incubation Time: 6 days
    Result: The growth of all six of the cell lines in culture was inhibited in a concentration-dependent manner with complete growth inhibition of the cell lines occurring at 10 µg/mL.
    体内研究
    (In Vivo)

    Pentamidine (0.25 mg/mouse; intramuscular injection; every 2 days; for 4 weeks; athymic nude mice) treatment markedly inhibits the growth of WM9 human melanoma tumors in nude mice[1].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Athymic nude mice (6 weeks old) injected with WM9 cells[1]
    Dosage: 0.25 mg/mouse
    Administration: Intramuscular injection; every 2 days; for 4 weeks
    Result: Markedly inhibited the growth of WM9 human melanoma tumors in nude mice.
    Clinical Trial
    分子量

    340.42

    Formula

    C19H24N4O2

    CAS 号
    性状

    固体

    颜色

    White to off-white

    中文名称

    喷他脒;喷它咪;戊烷脒;戊脘脒

    运输条件

    Room temperature in continental US; may vary elsewhere.

    储存方式

    4°C, protect from light

    *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

    溶解性数据
    细胞实验: 

    DMSO 中的溶解度 : 3.3 mg/mL (9.69 mM; ultrasonic and warming and adjust pH to 6 with 1 M HCL and heat to 60°C; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

    配制储备液
    浓度 溶剂体积 质量 1 mg 5 mg 10 mg
    1 mM 2.9375 mL 14.6877 mL 29.3755 mL
    5 mM 0.5875 mL 2.9375 mL 5.8751 mL
    查看完整储备液配制表

    * 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
    储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

    • 摩尔计算器

    • 稀释计算器

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    质量
    =
    浓度
    ×
    体积
    ×
    分子量 *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    浓度 (start)

    C1

    ×
    体积 (start)

    V1

    =
    浓度 (final)

    C2

    ×
    体积 (final)

    V2

    动物溶解方案计算器
    请输入动物实验的基本信息:

    给药剂量

    mg/kg

    动物的平均体重

    g

    每只动物的给药体积

    μL

    动物数量

    由于实验过程有损耗,建议您多配一只动物的量
    计算结果
    工作液所需浓度 : mg/mL
    纯度 & 产品资料

    纯度: 97.19%

    参考文献

    完整储备液配制表

    * 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
    储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

    可选溶剂 浓度 溶剂体积 质量 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 2.9375 mL 14.6877 mL 29.3755 mL 73.4387 mL
    5 mM 0.5875 mL 2.9375 mL 5.8751 mL 14.6877 mL
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    您最近查看的产品:

    Your information is safe with us. * Required Fields.

       产品名称:

     

    * 需求量:

    * 客户姓名:

     

    * Email:

    * 电话:

     

    * 公司或机构名称:

       留言给我们:

    Bulk Inquiry

    Inquiry Information

    产品名称:
    Pentamidine
    目录号:
    HY-B0537
    需求量: